Our study aimed to thoroughly characterize PDCD4 expression in human melanoma specimens and benign nevi and to evaluate the prognostic role of PDCD4 in tumor vs. immune-infiltrating cells using a large historical cohort of primary and metastatic melanoma specimens annotated for clinical outcome. Here, PDCD4 is linked to metastatic melanoma.